Your browser doesn't support javascript.
loading
Fatal Tumor Lysis Syndrome During Chemotherapy in Small Cell Lung Cancer / 결핵및호흡기질환
Article in Ko | WPRIM | ID: wpr-77098
Responsible library: WPRO
ABSTRACT
Tumor lysis syndrome is a life-threatening complication of anti-cancer therapy that typically occurs in patients with large, rapidly growing and treatment-sensitive tumors such as high-grade lymphomas and acute leukemias. However, its incidence in solid tumors has been known to be very low. Tumor lysis syndrome in solid tumors has a high mortality rate owing to the lack of prophylactic therapy to prevent this complication. We report a case of fatal tumor lysis syndrome developed during chemotherapy in extensive-stage small cell lung cancer, along with a brief review of the relevant literature considering the rarity of this manifestation in solid tumor.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Lymphoma, Non-Hodgkin / Tumor Lysis Syndrome / Leukemia / Incidence / Small Cell Lung Carcinoma Type of study: Incidence_studies / Prognostic_studies Limits: Humans Language: Ko Journal: Tuberculosis and Respiratory Diseases Year: 2008 Type: Article
Full text: 1 Index: WPRIM Main subject: Lymphoma, Non-Hodgkin / Tumor Lysis Syndrome / Leukemia / Incidence / Small Cell Lung Carcinoma Type of study: Incidence_studies / Prognostic_studies Limits: Humans Language: Ko Journal: Tuberculosis and Respiratory Diseases Year: 2008 Type: Article